Cardiovascular consequences of renal anaemia and erythropoietin therapy

被引：53

作者：

Eckardt, KU ^{[1
]}

机构：

[1] Humboldt Univ, Dept Nephrol & Med Intens Care, D-13353 Berlin, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1999年 / 14卷 / 05期

关键词：

anaemia; cardiac ischaemia; uraemic cardiomyopathy; erythropoietin;

D O I：

10.1093/ndt/14.5.1317

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：1317 / 1323

页数：7

共 64 条

[1] REDUCED CAPILLARY DENSITY IN THE MYOCARDIUM OF UREMIC RATS - A STEREOLOGICAL STUDY [J].

AMANN, K ;

WIEST, G ;

ZIMMER, G ;

GRETZ, N ;

RITZ, E ;

MALL, G .

KIDNEY INTERNATIONAL, 1992, 42 (05) :1079-1085

[2] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].

Besarab, A ;

Bolton, WK ;

Browne, JK ;

Egrie, JC ;

Nissenson, AR ;

Okamoto, DM ;

Schwab, SJ ;

Goodkin, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590

[3]

CANNELLA G, 1990, CLIN NEPHROL, V34, P272

[4] REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE DIALYZED UREMIC PATIENTS ON LONG-TERM ANTIHYPERTENSIVE THERAPY [J].

CANNELLA, G ;

PAOLETTI, E ;

DELFINO, R ;

PELOSO, G ;

MOLINARI, S ;

TRAVERSO, GB .

KIDNEY INTERNATIONAL, 1993, 44 (04) :881-886

[5] RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) INCREASES ENDOTHELIN-1 RELEASE BY ENDOTHELIAL-CELLS [J].

CARLINI, RG ;

DUSSO, AS ;

OBIALO, CI ;

ALVAREZ, UM ;

ROTHSTEIN, M .

KIDNEY INTERNATIONAL, 1993, 43 (05) :1010-1014

[6] HEMODYNAMIC RESPONSE TO CHRONIC ANEMIA [J].

DUKE, M ;

ABELMANN, WH .

CIRCULATION, 1969, 39 (04) :503-&

[7] ERYTHROPOIETIN - OXYGEN-DEPENDENT CONTROL OF ERYTHROPOIESIS AND ITS FAILURE IN RENAL-DISEASE [J].

ECKARDT, KU .

NEPHRON, 1994, 67 (01) :7-23

[8] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].

ESCHBACH, JW ;

EGRIE, JC ;

DOWNING, MR ;

BROWNE, JK ;

ADAMSON, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78

[9] CARDIOVASCULAR CONSEQUENCES OF CORRECTION OF THE ANEMIA OF RENAL-FAILURE WITH ERYTHROPOIETIN [J].

FELLNER, SK ;

LANG, RM ;

NEUMANN, A ;

KORCARZ, C ;

BOROW, KM .

KIDNEY INTERNATIONAL, 1993, 44 (06) :1309-1315

[10] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT ON HEMODYNAMIC PARAMETERS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND HEMODIALYSIS-PATIENTS [J].

FERNANDEZ, A ;

VEGA, N ;

JIMENEZ, F ;

MACIA, M ;

LARAUDIOGOITIA, E ;

HORTAL, L ;

PERDOMO, M ;

PLAZA, C ;

RODRIGUEZ, JC ;

PALOP, L .

AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (04) :207-211

← 1 2 3 4 5 6 7 →